This NGS-based panel evaluates genes responsible for citrullinemia, a urea cycle disorder that can lead to harmful ammonia buildup in the body. Metropolis Healthcare uses advanced sequencing methods to detect pathogenic variants linked to both Type I and Type II citrullinemia. The test supports early diagnosis, timely intervention, and informed clinical management. A blood sample collected in an EDTA vial is required for this analysis.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0175
Frequently Asked Questions (FAQ's):
What does the Citrullinemia Gene Panel include at Metropolis Healthcare?
It includes targeted NGS analysis of key genes associated with Type I and Type II citrullinemia.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-depth Next-Generation Sequencing to identify disease-causing variants with precision.
Who should consider taking this test at Metropolis Healthcare?
It is recommended for individuals with unexplained high ammonia levels, neurological symptoms, or a family history of urea cycle disorders.
What type of sample is required for this test at Metropolis Healthcare?
A blood sample collected in an EDTA tube is used for genetic sequencing.
How can this test support treatment decisions?
Identifying the genetic subtype helps guide dietary management, medication choices, and long-term monitoring.
How long does Metropolis Healthcare take to deliver the report?
The typical turnaround time is 2–4 weeks depending on sequencing complexity.
Can this panel detect carriers of citrullinemia?
Yes, the test can identify carriers, which is helpful for family planning and genetic counseling.
Is genetic counseling recommended after receiving results from Metropolis Healthcare?
Yes, counseling helps interpret results and understand inheritance risks.